Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
GSK’s Blenrep: 15 Days From Confirmatory Trial Failure To Withdrawal Announcement
Nov 28 2022
•
By
Sue Sutter
FDA and GSK moved with considerable speed in taking Blenrep off the market followed a failed confirmatory trial. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Review Pathways
More from Pathways & Standards